{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T20:46:21Z","timestamp":1785876381040,"version":"3.56.0"},"reference-count":81,"publisher":"Scientific Scholar","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2017,1]]},"abstract":"<jats:sec>\n            <jats:title\/>\n            <jats:p>Bipolar disorder (BD) is a severe, recurrent mood disorder, associated with a significant morbidity and mortality, with high rates of suicides and medical comorbidities. There is a high risk of mood disorders among the first-degree relatives of patients with BD. In the current clinical practice, the diagnosis of BD is made by history taking, interview and behavioural observations, thereby lacking an objective, biological validation. This approach may result in underdiagnosis, misdiagnosis and eventually poorer outcomes. Due to the heterogeneity of BD, the possibility of developing a single, specific biomarker is still remote; however, there is a set of promising biomarkers which may serve as predictive, prognostic or treatment markers in the future. The review presents a critical appraisal and update on some of the most promising candidates for biomarkers, namely, neuroimaging markers, peripheral biomarkers and genetic markers, including a brief discussion on cognitive endophenotypes as indicative of genetic risk. The lessons learnt from other fields and specialties in medicine need to be applied to psychiatry to translate the knowledge from \u2018bench to bedside\u2019 by means of clinically useful biomarkers. Overall, the biomarkers may help in pushing the shift towards personalized medicine for psychiatric patients.<\/jats:p>\n          <\/jats:sec>","DOI":"10.4103\/ijmr.ijmr_1386_16","type":"journal-article","created":{"date-parts":[[2017,5,29]],"date-time":"2017-05-29T12:31:30Z","timestamp":1496061090000},"page":"7-16","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":50,"title":["Potential biomarkers for bipolar disorder"],"prefix":"10.25259","volume":"145","author":[{"given":"Rajesh","family":"Sagar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raman Deep","family":"Pattanayak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10894","reference":[{"key":"R1-3-20241212","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1146\/annurev.clinpsy.3.022806.091444","article-title":"Prevalence, comorbidity, and service utilization for mood disorders in the United States at the beginning of the twenty-first century","volume":"3","author":"Kessler","year":"2007","journal-title":"Annu Rev Clin Psychol"},{"key":"R2-3-20241212","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1001\/archgenpsychiatry.2011.12","article-title":"Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative","volume":"68","author":"Merikangas","year":"2011","journal-title":"Arch Gen Psychiatry"},{"key":"R3-3-20241212","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/S0140-6736(13)61611-6","article-title":"Global burden of disease attributable to mental and substance use disorders: Findings from the Global Burden of Disease Study 2010","volume":"382","author":"Whiteford","year":"2013","journal-title":"Lancet"},{"key":"R4-3-20241212","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/nrd1130","article-title":"Clinical biomarkers in drug discovery and development","volume":"2","author":"Frank","year":"2003","journal-title":"Nat Rev Drug Discov"},{"key":"R5-3-20241212","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3389\/fpsyt.2012.00114","article-title":"Biomarkers in psychiatry: How close are we?","volume":"3","author":"Kobeissy","year":"2013","journal-title":"Front Psychiatry"},{"key":"R7-3-20241212","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1177\/0004867413478217","article-title":"Biomarkers in bipolar disorder: A positional paper from the International Society for Bipolar Disorders Biomarkers Task Force","volume":"47","author":"Frey","year":"2013","journal-title":"Aust N Z J Psychiatry"},{"key":"R8-3-20241212","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s11920-013-0425-9","article-title":"Toward clinically applicable biomarkers in bipolar disorder: Focus on BDNF, inflammatory markers, and endothelial function","volume":"15","author":"Goldstein","year":"2013","journal-title":"Curr Psychiatry Rep"},{"key":"R9-3-20241212","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1080\/09540260902962198","article-title":"Hyperintense MRI lesions in bipolar disorder: A meta-analysis and review","volume":"21","author":"Beyer","year":"2009","journal-title":"Int Rev Psychiatry"},{"key":"R10-3-20241212","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.biopsych.2010.08.029","article-title":"Structural magnetic resonance imaging in bipolar disorder: An international collaborative mega-analysis of individual adult patient data","volume":"69","author":"Hallahan","year":"2011","journal-title":"Biol Psychiatry"},{"key":"R11-3-20241212","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.arcmed.2005.04.009","article-title":"T2 hyperintensities in bipolar patients and their healthy siblings","volume":"37","author":"Gulseren","year":"2006","journal-title":"Arch Med Res"},{"key":"R12-3-20241212","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1001\/archpsyc.65.9.1017","article-title":"Meta-analysis, database, and meta-regression of 98 structural imaging studies in bipolar disorder","volume":"65","author":"Kempton","year":"2008","journal-title":"Arch Gen Psychiatry"},{"key":"R13-3-20241212","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1176\/appi.ajp.159.11.1841","article-title":"Ventricular and periventricular structural volumes in first- versus multiple-episode bipolar disorder","volume":"159","author":"Strakowski","year":"2002","journal-title":"Am J Psychiatry"},{"key":"R14-3-20241212","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1192\/bjp.bp.108.059717","article-title":"Magnetic resonance imaging studies in bipolar disorder and schizophrenia: Meta-analysis","volume":"195","author":"Arnone","year":"2009","journal-title":"Br J Psychiatry"},{"key":"R15-3-20241212","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1176\/appi.ajp.2014.13081008","article-title":"A critical appraisal of neuroimaging studies of bipolar disorder: Toward a new conceptualization of underlying neural circuitry and a road map for future research","volume":"171","author":"Phillips","year":"2014","journal-title":"Am J Psychiatry"},{"key":"R16-3-20241212","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1097\/CHI.0b013e318185d299","article-title":"Meta-analysis of amygdala volumes in children and adolescents with bipolar disorder","volume":"47","author":"Pfeifer","year":"2008","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"R17-3-20241212","doi-asserted-by":"crossref","first-page":"699","DOI":"10.4088\/JCP.07m03745","article-title":"A longitudinal study of the effects of lithium treatment on prefrontal and subgenual prefrontal gray matter volume in treatment-responsive bipolar disorder patients","volume":"70","author":"Moore","year":"2009","journal-title":"J Clin Psychiatry"},{"key":"R18-3-20241212","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/WNR.0b013e3282f48108","article-title":"Increased volume of the amygdala and hippocampus in bipolar patients treated with lithium","volume":"19","author":"Foland","year":"2008","journal-title":"Neuroreport"},{"key":"R19-3-20241212","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1038\/sj.npp.1301507","article-title":"Three-dimensional mapping of hippocampal anatomy in unmedicated and lithium-treated patients with bipolar disorder","volume":"33","author":"Bearden","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"R20-3-20241212","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1016\/j.pnpbp.2011.05.009","article-title":"A meta-analysis of whole-brain diffusion tensor imaging studies in bipolar disorder","volume":"35","author":"Vederine","year":"2011","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"R21-3-20241212","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s00702-010-0368-9","article-title":"White matter abnormalities in bipolar disorder: Insights from diffusion tensor imaging studies","volume":"117","author":"Heng","year":"2010","journal-title":"J Neural Transm (Vienna"},{"key":"R22-3-20241212","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/j.1399-5618.2011.00938.x","article-title":"Tract-specific white matter structural disruption in patients with bipolar disorder","volume":"13","author":"Benedetti","year":"2011","journal-title":"Bipolar Disord"},{"key":"R23-3-20241212","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.neubiorev.2009.01.004","article-title":"Bipolar and major depressive disorder: Neuroimaging the developmental-degenerative divide","volume":"33","author":"Savitz","year":"2009","journal-title":"Neurosci Biobehav Rev"},{"key":"R24-3-20241212","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jad.2011.03.016","article-title":"Neuroimaging-based markers of bipolar disorder: Evidence from two meta-analyses","volume":"132","author":"Houenou","year":"2011","journal-title":"J Affect Disord"},{"key":"R25-3-20241212","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.biopsych.2009.09.027","article-title":"Elevated amygdala activity to sad facial expressions: A state marker of bipolar but not unipolar depression","volume":"67","author":"Almeida","year":"2010","journal-title":"Biol Psychiatry"},{"key":"R26-3-20241212","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1399-5618.2011.00893.x","article-title":"A quantitative meta-analysis of fMRI studies in bipolar disorder","volume":"13","author":"Chen","year":"2011","journal-title":"Bipolar Disord"},{"key":"R27-3-20241212","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.biopsych.2008.04.038","article-title":"Genetic liability for bipolar disorder is characterized by excess frontal activation in response to a working memory task","volume":"64","author":"Drapier","year":"2008","journal-title":"Biol Psychiatry"},{"key":"R28-3-20241212","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1002\/ajmg.b.30964","article-title":"An fMRI study of working memory in persons with bipolar disorder or at genetic risk for bipolar disorder","volume":"153B","author":"Thermenos","year":"2010","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"R29-3-20241212","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.euroneuro.2011.07.003","article-title":"Common and distinct neural correlates of emotional processing in bipolar disorder and major depressive disorder: A voxel-based meta-analysis of functional magnetic resonance imaging studies","volume":"22","author":"Delvecchio","year":"2012","journal-title":"Eur Neuropsychopharmacol"},{"key":"R30-3-20241212","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1007\/s11920-014-0514-4","article-title":"Current state of biomarkers in bipolar disorder","volume":"16","author":"Scola","year":"2014","journal-title":"Curr Psychiatry Rep"},{"key":"R31-3-20241212","first-page":"S232","article-title":"A functional neuroimaging investigation of brain pathways involved in patients during active mania using stroop colour word test","volume":"33","author":"Gupta","year":"2016","journal-title":"Eur Psychiatry"},{"key":"R32-3-20241212","first-page":"S405","article-title":"An fMRI study in patients with active mania using verbal n-back test","volume":"33","author":"Gupta","year":"2016","journal-title":"Eur Psychiatry"},{"key":"R33-3-20241212","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jpsychires.2014.05.018","article-title":"Diagnostic and clinical implications of functional neuroimaging in bipolar disorder","volume":"57","author":"Brooks","year":"2014","journal-title":"J Psychiatr Res"},{"key":"R34-3-20241212","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1007\/s11920-007-0070-2","article-title":"Neuroimaging in bipolar disorder: A critical review of current findings","volume":"9","author":"Keener","year":"2007","journal-title":"Curr Psychiatry Rep"},{"key":"R35-3-20241212","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.pnpbp.2008.11.014","article-title":"Brain glucose metabolism difference between bipolar and unipolar mood disorders in depressed and euthymic states","volume":"33","author":"Hosokawa","year":"2009","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"R36-3-20241212","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/j.1399-5618.2005.00266.x","article-title":"N-acetylaspartate levels in bipolar offspring with and at high-risk for bipolar disorder","volume":"7","author":"Gallelli","year":"2005","journal-title":"Bipolar Disord"},{"key":"R37-3-20241212","first-page":"531","article-title":"A comparison of affected and unaffected relatives of patients with bipolar disorder using proton magnetic resonance spectroscopy","volume":"33","author":"Hajek","year":"2008","journal-title":"J Psychiatry Neurosci"},{"key":"R38-3-20241212","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.biopsych.2010.06.016","article-title":"Magnetic resonance spectroscopy studies of glutamate-related abnormalities in mood disorders","volume":"68","author":"Y\u00fcksel","year":"2010","journal-title":"Biol Psychiatry"},{"key":"R39-3-20241212","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0006-3223(00)00252-3","article-title":"Lithium increases N-acetylaspartate in the human brain: In vivo evidence in support of bcl-2's neurotrophic effects?","volume":"48","author":"Moore","year":"2000","journal-title":"Biol Psychiatry"},{"key":"R40-3-20241212","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jad.2016.01.039","article-title":"Can neuroimaging disentangle bipolar disorder?","volume":"195","author":"Hozer","year":"2016","journal-title":"J Affect Disord"},{"key":"R41-3-20241212","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1176\/appi.ajp.2012.12020169","article-title":"Ventral striatum activity in response to reward: Differences between bipolar I and II disorders","volume":"170","author":"Caseras","year":"2013","journal-title":"Am J Psychiatry"},{"key":"R42-3-20241212","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jpsychires.2010.05.015","article-title":"Peripheral biomarkers and illness activity in bipolar disorder","volume":"45","author":"Kapczinski","year":"2011","journal-title":"J Psychiatr Res"},{"key":"R43-3-20241212","doi-asserted-by":"crossref","first-page":"243","DOI":"10.4306\/pi.2010.7.4.243","article-title":"The role of BDNF as a mediator of neuroplasticity in bipolar disorder","volume":"7","author":"Grande","year":"2010","journal-title":"Psychiatry Investig"},{"key":"R44-3-20241212","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.jpsychires.2011.03.002","article-title":"Brain-derived neurotrophic factor as a state-marker of mood episodes in bipolar disorders: A systematic review and meta-regression analysis","volume":"45","author":"Fernandes","year":"2011","journal-title":"J Psychiatr Res"},{"key":"R45-3-20241212","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1017\/S1461145708009449","article-title":"Accelerated age-related decrease in brain-derived neurotrophic factor levels in bipolar disorder","volume":"12","author":"Yatham","year":"2009","journal-title":"Int J Neuropsychopharmacol"},{"key":"R46-3-20241212","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1017\/S1461145708009310","article-title":"Brain-derived neurotrophic factor and inflammatory markers in patients with early- vs. late-stage bipolar disorder","volume":"12","author":"Kauer-Sant\u2019Anna","year":"2009","journal-title":"Int J Neuropsychopharmacol"},{"key":"R47-3-20241212","doi-asserted-by":"crossref","first-page":"272e4","DOI":"10.1111\/j.1601-5215.2009.00410.x","article-title":"The concept of staging in bipolar disorder: The role of BDNF and TNF-alpha as biomarkers","volume":"21","author":"Kapczinski","year":"2009","journal-title":"Acta Neuropsychiatr"},{"key":"R48-3-20241212","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.jpsychires.2009.04.010","article-title":"Serum brain-derived neurotrophic factor in bipolar and unipolar depression: A potential adjunctive tool for differential diagnosis","volume":"43","author":"Fernandes","year":"2009","journal-title":"J Psychiatr Res"},{"key":"R49-3-20241212","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.jad.2014.11.044","article-title":"BDNF as a biomarker for successful treatment of mood disorders: A systematic and quantitative meta-analysis","volume":"174","author":"Polyakova","year":"2015","journal-title":"J Affect Disord"},{"key":"R50-3-20241212","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1186\/s12916-015-0529-7","article-title":"Peripheral brain-derived neurotrophic factor (BDNF) as a biomarker in bipolar disorder: A meta-analysis of 52 studies","volume":"13","author":"Fernandes","year":"2015","journal-title":"BMC Med"},{"key":"R51-3-20241212","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.neulet.2011.02.054","article-title":"Lithium increases plasma brain-derived neurotrophic factor in acute bipolar mania: A preliminary 4-week study","volume":"494","author":"de Sousa","year":"2011","journal-title":"Neurosci Lett"},{"key":"R52-3-20241212","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.neulet.2009.01.028","article-title":"Brain-derived neurotrophic factor serum levels before and after treatment for acute mania","volume":"452","author":"Tramontina","year":"2009","journal-title":"Neurosci Lett"},{"key":"R53-3-20241212","first-page":"66","article-title":"Correlation of serum BDNF level with clinical symptom domains in Bipolar Disorder-I","volume":"16","author":"Chatterjee","year":"2014","journal-title":"Bipolar Disord"},{"key":"R54-3-20241212","first-page":"81","article-title":"Association of serum BDNF with verbal and visual memory deficit in subjects with Bipolar Disorder I","volume":"16","author":"Chatterjee","year":"2014","journal-title":"Bipolar Disord"},{"key":"R55-3-20241212","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.jpsychires.2013.05.018","article-title":"Cytokines in bipolar disorder vs. healthy control subjects: A systematic review and meta-analysis","volume":"47","author":"Munkholm","year":"2013","journal-title":"J Psychiatr Res"},{"key":"R56-3-20241212","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jad.2007.02.018","article-title":"Imbalance between pro-inflammatory and anti-inflammatory cytokines in bipolar disorder","volume":"104","author":"Kim","year":"2007","journal-title":"J Affect Disord"},{"key":"R57-3-20241212","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jad.2008.12.001","article-title":"Comparison of cytokine levels in depressed, manic and euthymic patients with bipolar disorder","volume":"116","author":"Brietzke","year":"2009","journal-title":"J Affect Disord"},{"key":"R58-3-20241212","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/pmic.201000291","article-title":"Peripheral profiling analysis for bipolar disorder reveals markers associated with reduced cell survival","volume":"11","author":"Herberth","year":"2011","journal-title":"Proteomics"},{"key":"R59-3-20241212","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/pmic.201000371","article-title":"Apolipoprotein A-I as a candidate serum marker for the response to lithium treatment in bipolar disorder","volume":"11","author":"Sussulini","year":"2011","journal-title":"Proteomics"},{"key":"R60-3-20241212","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1016\/j.jpsychires.2011.08.003","article-title":"Affective symptoms are associated with markers of inflammation and immune activation in bipolar disorders but not in schizophrenia","volume":"45","author":"Hope","year":"2011","journal-title":"J Psychiatr Res"},{"key":"R61-3-20241212","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.neubiorev.2010.10.001","article-title":"Pathways underlying neuroprogression in bipolar disorder: Focus on inflammation, oxidative stress and neurotrophic factors","volume":"35","author":"Berk","year":"2011","journal-title":"Neurosci Biobehav Rev"},{"key":"R62-3-20241212","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.psychres.2014.04.005","article-title":"An updated meta-analysis of oxidative stress markers in bipolar disorder","volume":"218","author":"Brown","year":"2014","journal-title":"Psychiatry Res"},{"key":"R63-3-20241212","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jad.2008.04.013","article-title":"Oxidative stress markers in bipolar disorder: A meta-analysis","volume":"111","author":"Andreazza","year":"2008","journal-title":"J Affect Disord"},{"key":"R65-3-20241212","doi-asserted-by":"crossref","first-page":"7501","DOI":"10.1073\/pnas.0813386106","article-title":"Genome-wide association and meta-analysis of bipolar disorder in individuals of European ancestry","volume":"106","author":"Scott","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R66-3-20241212","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1001\/jamapsychiatry.2014.176","article-title":"Identification of pathways for bipolar disorder: A meta-analysis","volume":"71","author":"Nurnberger","year":"2014","journal-title":"JAMA Psychiatry"},{"key":"R67-3-20241212","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jpsychires.2010.04.028","article-title":"MicroRNA-134 plasma levels before and after treatment for bipolar mania","volume":"45","author":"Rong","year":"2011","journal-title":"J Psychiatr Res"},{"key":"R68-3-20241212","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jad.2015.05.017","article-title":"The genetics of early-onset bipolar disorder: A systematic review","volume":"184","author":"Kennedy","year":"2015","journal-title":"J Affect Disord"},{"key":"R69-3-20241212","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/466827a","article-title":"Behavioural neuroscience: Genes and the anxious brain","volume":"466","author":"Meyer-Lindenberg","year":"2010","journal-title":"Nature"},{"key":"R70-3-20241212","first-page":"2325","article-title":"Association of Per3 length polymorphism with bipolar I disorder and schizophrenia","volume":"10","author":"Karthikeyan","year":"2014","journal-title":"Neuropsychiatr Dis Treat"},{"key":"R71-3-20241212","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1176\/appi.ajp.160.4.636","article-title":"The endophenotype concept in psychiatry: Etymology and strategic intentions","volume":"160","author":"Gottesman","year":"2003","journal-title":"Am J Psychiatry"},{"key":"R72-3-20241212","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/acps.12133","article-title":"Neuropsychological testing of cognitive impairment in euthymic bipolar disorder: An individual patient data meta-analysis","volume":"128","author":"Bourne","year":"2013","journal-title":"Acta Psychiatr Scand"},{"key":"R73-3-20241212","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1017\/S0033291707001675","article-title":"Meta-analyses of cognitive functioning in euthymic bipolar patients and their first-degree relatives","volume":"38","author":"Arts","year":"2008","journal-title":"Psychol Med"},{"key":"R74-3-20241212","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jad.2008.06.009","article-title":"Cognitive endophenotypes of bipolar disorder: A meta-analysis of neuropsychological deficits in euthymic patients and their first-degree relatives","volume":"113","author":"Bora","year":"2009","journal-title":"J Affect Disord"},{"key":"R75-3-20241212","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1007\/s00702-016-1581-y","article-title":"Cognitive deficits in first-degree relatives of bipolar patients: The use of homogeneous subgroups in the search of cognitive endophenotypes","volume":"123","author":"Volkert","year":"2016","journal-title":"J Neural Transm (Vienna"},{"key":"R76-3-20241212","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s11920-015-0605-x","article-title":"Neuroprogression and cognitive functioning in bipolar disorder: A systematic review","volume":"17","author":"Cardoso","year":"2015","journal-title":"Curr Psychiatry Rep"},{"key":"R77-3-20241212","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/j.1440-1819.2012.02400.x","article-title":"Neuropsychological performance in euthymic Indian patients with bipolar disorder type I: Correlation between quality of life and global functioning","volume":"66","author":"Pattanayak","year":"2012","journal-title":"Psychiatry Clin Neurosci"},{"key":"R78-3-20241212","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jad.2006.03.013","article-title":"Comparison of cognitive functions between first- and multi-episode bipolar affective disorders","volume":"93","author":"Nehra","year":"2006","journal-title":"J Affect Disord"},{"key":"R79-3-20241212","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/j.1440-1819.2008.01844.x","article-title":"Cognitive functions in bipolar affective disorder and schizophrenia: Comparison","volume":"62","author":"Pradhan","year":"2008","journal-title":"Psychiatry Clin Neurosci"},{"key":"R80-3-20241212","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1080\/13546800801897346","article-title":"Cognitive functions in euthymic state of bipolar disorder: An Indian study","volume":"13","author":"Trivedi","year":"2008","journal-title":"Cogn Neuropsychiatry"},{"key":"R81-3-20241212","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/j.1600-0447.2009.01390.x","article-title":"The neurocognitive performance of drug-free and medicated euthymic bipolar patients do not differ","volume":"120","author":"Goswami","year":"2009","journal-title":"Acta Psychiatr Scand"},{"key":"R82-3-20241212","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1111\/j.1399-5618.2010.00857.x","article-title":"Impairment of verbal learning and memory and executive function in unaffected siblings of probands with bipolar disorder","volume":"12","author":"Kulkarni","year":"2010","journal-title":"Bipolar Disord"},{"key":"R83-3-20241212","first-page":"18","article-title":"Cognitive dysfunction as a trait marker for bipolar disorder: A critical review","volume":"16","author":"Pattanayak","year":"2011","journal-title":"J Ment Health Hum Behav"}],"container-title":["Indian Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/02223309-201745010-00003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T23:02:09Z","timestamp":1751497329000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijmr.org.in\/potential-biomarkers-for-bipolar-disorder-where-do-we-stand\/"}},"subtitle":["Where do we stand?"],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":81,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.4103\/ijmr.ijmr_1386_16","relation":{},"ISSN":["0971-5916"],"issn-type":[{"value":"0971-5916","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]}}}